Danaher Corp
DHR219.620USD
-4.920-2.19%
Close 01/29, 16:00（ET）Quotes delayed by 15 min
155.25BMarket Cap
43.31P/E TTM
More Details of Danaher Corp Company
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Danaher Corp Info
Ticker SymbolDHR
Company nameDanaher Corp
IPO dateJan 16, 2106
CEOBlair (Rainer M)
Number of employees61000
Security typeOrdinary Share
Fiscal year-endJan 16
Address2200 Pennsylvania Ave NW Ste 800W
CityWASHINGTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code20037-1701
Phone12028280850
Websitehttps://www.danaher.com/
Ticker SymbolDHR
IPO dateJan 16, 2106
CEOBlair (Rainer M)
Company Executives of Danaher Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
-1250000.00%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.90M
-437000.00%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
85.52K
+577.00%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
46.53K
-27490.00%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
41.54K
+2719.00%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President
Senior Vice President
22.53K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
Independent Director
Independent Director
16.19K
+2719.00%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Senior Vice President - Corporate Development
Senior Vice President - Corporate Development
16.02K
-4701.00%
Prof. Raymond C. Stevens, Ph.D.
Prof. Raymond C. Stevens, Ph.D.
Independent Director
Independent Director
6.96K
+577.00%
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Senior Vice President, Chief Science Officer
Senior Vice President, Chief Science Officer
5.71K
+2718.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
-1250000.00%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.90M
-437000.00%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
85.52K
+577.00%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
46.53K
-27490.00%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
41.54K
+2719.00%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President
Senior Vice President
22.53K
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
All Other
11.14B
46.67%
United States
9.93B
41.58%
China
2.81B
11.75%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.58%
Rales (Steven M)
5.98%
Rales (Mitchell P)
4.79%
BlackRock Institutional Trust Company, N.A.
4.12%
State Street Investment Management (US)
3.85%
Other
72.68%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.58%
Rales (Steven M)
5.98%
Rales (Mitchell P)
4.79%
BlackRock Institutional Trust Company, N.A.
4.12%
State Street Investment Management (US)
3.85%
Other
72.68%
Shareholder Types
Shareholders
Proportion
Investment Advisor
46.38%
Investment Advisor/Hedge Fund
25.92%
Individual Investor
10.84%
Research Firm
2.68%
Pension Fund
2.31%
Hedge Fund
2.17%
Bank and Trust
2.16%
Sovereign Wealth Fund
1.52%
Family Office
0.37%
Other
5.64%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
3713
600.67M
84.70%
+80.00
2025Q3
3823
600.80M
83.72%
+9.92M
2025Q2
3884
590.58M
83.08%
+3.57M
2025Q1
3906
588.12M
83.05%
-6.10M
2024Q4
3917
584.70M
83.45%
-1.93M
2024Q3
3784
586.76M
84.40%
-9.93M
2024Q2
3730
596.69M
83.29%
-8.16M
2024Q1
3735
604.73M
82.65%
-7.38M
2023Q4
3745
604.00M
82.08%
+5.49M
2023Q3
3652
599.98M
81.85%
+5.75M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
60.59M
8.58%
+114.41K
+0.19%
Sep 30, 2025
Rales (Steven M)
42.24M
5.98%
-1.25M
-2.87%
May 12, 2025
Rales (Mitchell P)
33.90M
4.8%
-437.00K
-1.27%
Nov 26, 2025
BlackRock Institutional Trust Company, N.A.
29.10M
4.12%
+218.28K
+0.76%
Sep 30, 2025
State Street Investment Management (US)
27.21M
3.85%
-90.79K
-0.33%
Sep 30, 2025
Capital International Investors
16.76M
2.37%
+312.95K
+1.90%
Sep 30, 2025
Geode Capital Management, L.L.C.
13.85M
1.96%
+123.22K
+0.90%
Sep 30, 2025
T. Rowe Price Associates, Inc.
13.67M
1.94%
-1.99M
-12.72%
Sep 30, 2025
Fidelity Management & Research Company LLC
13.57M
1.92%
+623.30K
+4.81%
Sep 30, 2025
Wellington Management Company, LLP
13.56M
1.92%
-3.52M
-20.60%
Sep 30, 2025
View more
Related ETFs
Updated: Wed, Nov 5
Updated: Wed, Nov 5
Name
Proportion
Parnassus Core Select ETF
6.32%
VanEck Morningstar Wide Moat Value ETF
4.47%
iShares ESG Aware MSCI USA Value ETF
3.95%
Macquarie Focused Large Growth ETF
3.91%
Monarch Blue Chips Core ETF
3.82%
Eagle Capital Select Equity ETF
3.63%
Madison Covered Call ETF
3.37%
iREIT MarketVector Quality REIT Index ETF
3.35%
JPMorgan Healthcare Leaders ETF
3.23%
FMC Excelsior Focus Equity ETF
3.13%
View more
Parnassus Core Select ETF
Proportion6.32%
VanEck Morningstar Wide Moat Value ETF
Proportion4.47%
iShares ESG Aware MSCI USA Value ETF
Proportion3.95%
Macquarie Focused Large Growth ETF
Proportion3.91%
Monarch Blue Chips Core ETF
Proportion3.82%
Eagle Capital Select Equity ETF
Proportion3.63%
Madison Covered Call ETF
Proportion3.37%
iREIT MarketVector Quality REIT Index ETF
Proportion3.35%
JPMorgan Healthcare Leaders ETF
Proportion3.23%
FMC Excelsior Focus Equity ETF
Proportion3.13%
Dividend
A total of
3.15B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Dec 09, 2025
DHR.NB Final Cash Dividend of gross USD 0.32 paid on Jan 30, 2026 going ex on Dec 26, 2025
Dec 26, 2025
Jan 30, 2026
Dec 26, 2025
Sep 09, 2025
DHR.NB Final Cash Dividend of gross USD 0.32 paid on Oct 31, 2025 going ex on Sep 26, 2025
Sep 26, 2025
Oct 31, 2025
Sep 26, 2025
May 06, 2025
DHR.NB Interim Cash Dividend of gross USD 0.32 paid on Jul 25, 2025 going ex on Jun 27, 2025
Jun 27, 2025
Jul 25, 2025
Jun 27, 2025
Feb 20, 2025
DHR.NB Interim Cash Dividend of gross USD 0.32 paid on Apr 25, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 25, 2025
Mar 28, 2025
Dec 10, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jan 31, 2025 going ex on Dec 27, 2024
Dec 27, 2024
Jan 31, 2025
Dec 27, 2024
Sep 10, 2024
DHR.NB Final Cash Dividend of gross USD 0.27 paid on Oct 25, 2024 going ex on Sep 27, 2024
Sep 27, 2024
Oct 25, 2024
Sep 27, 2024
May 07, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jul 26, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 26, 2024
Jun 28, 2024
Feb 21, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Apr 26, 2024 going ex on Mar 27, 2024
Mar 28, 2024
Apr 26, 2024
Mar 27, 2024
Dec 05, 2023
DHR.NB Interim Cash Dividend of gross USD 0.24 paid on Jan 26, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 26, 2024
Dec 28, 2023
Sep 13, 2023
DHR.NB Final Cash Dividend of gross USD 0.27 paid on Oct 27, 2023 going ex on Oct 11, 2023
Oct 12, 2023
Oct 27, 2023
Oct 11, 2023
View more
Stock Split
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
